Oncology Times - OncTimes Talk
By Unknown
Listen to a podcast, please open Podcast Republic app. Available on Google Play Store and Apple App Store.
Image by Unknown
Category: Science
Open in Apple Podcasts
Open RSS feed
Open Website
Rate for this podcast
Subscribers: 4
Reviews: 0
Episodes: 139
Description
Oncology Times reports essential clinical news for oncologists, hematologists and other cancer care professionals. Learn more about our award-winning journal!
| Episode | Date |
|---|---|
|
Clinical Study Shows Selective PARP 1 Inhibitor More Effective, Less Toxic
|
May 16, 2024 |
|
Exercise Deters Prostate Cancer Death & Progression
|
May 16, 2024 |
|
Bispecific Dual Checkpoint Blockade Extends Life & Slows Progression in Gastric & GE Junction Cancers
|
May 16, 2024 |
|
Bispecific T-cell Engager Antibody Brings Deep, Durable Remissions in R/R Multiple Myeloma
|
May 02, 2024 |
|
Exosome-Based Liquid Biopsy Promises Very Early Pancreatic Cancer Detection
|
May 02, 2024 |
|
Polyepitopic Personalized Vaccine Brought Durable Immune Responses & Clinical Benefit in Resected Head & Neck Cancers
|
May 02, 2024 |
|
Mesh-Supported Prepectoral Method of Breast Reconstruction After Breast Cancer Surgery
|
Apr 29, 2024 |
|
Radiotherapy Boost Protects Young Patients With Early Breast Cancer, High Dose Boost Not Needed
|
Apr 29, 2024 |
|
Breast-Conserving Therapy Effective for Ductal Carcinoma in Situ, But Questions Remain
|
Apr 26, 2024 |
|
Three-Node Breast Cancer Spread: Most Patients Can Safely Avoid Axillary Dissection
|
Apr 26, 2024 |
|
Artificial Intelligence Tool Predicts Postoperative Radiotherapy Lymphedema
|
Apr 15, 2024 |
|
Neoadjuvant Pembrolizumab Improves High-Risk Early Breast Cancer Outcomes
|
Apr 15, 2024 |
|
Preoperative Partial Breast Irradiation: Marked Benefit in Low-Risk Breast Cancer
|
Apr 12, 2024 |
|
Adjuvant Atezolizumab: No Survival Benefit in Triple-Negative Breast Cancer
|
Apr 11, 2024 |
|
Gene Test Shows Which Triple-Negative Breast Cancers Do Not Need Pre-Op Pembrolizumab
|
Mar 27, 2024 |
|
Triple Therapy for Patients With Mutated FLT3 Gene in Acute Myeloid Leukemia
|
Mar 22, 2024 |
|
Important Mantle Cell Lymphoma Findings From the Sympatico Study
|
Mar 12, 2024 |
|
World’s Largest Prostate Cancer Trial, STAMPEDE, Celebrates 20 Years of Progress
|
Mar 06, 2024 |
|
Doublet Inhibitor Therapy Restrains Metastatic EGFR-Mutated NSCLC Progression
|
Mar 04, 2024 |
|
Gene-Targeted Agent Brings Clinical Benefit in R/R Acute Leukemias
|
Feb 29, 2024 |
|
INTERLACE Study Boosts Cervical Cancer Survival
|
Feb 28, 2024 |
|
RET Fusion-Targeted Drug Doubles Progression-Free Survival in NSCLC Patients
|
Feb 16, 2024 |
|
Afatinib Recommended for Non-Small Cell Lung Cancer With Uncommon EGFR Mutations
|
Feb 16, 2024 |
|
Adjuvant Radiotherapy No Benefit After Radical Prostatectomy
|
Feb 14, 2024 |
|
Collagen-Bound Interleukin 12 Converts “Cold” Tumors Into “Hot” Ones
|
Feb 14, 2024 |
|
Allogeneic Transplant for AML: Only in Patients Negative for Molecular Minimum Residual Disease
|
Feb 07, 2024 |
|
Antibody-Drug Conjugate Brings Success in High-Risk R/R Follicular Lymphoma
|
Feb 06, 2024 |
|
Pirtobrutinib After Covalent BTK Inhibitor - Double Refractory CLL
|
Jan 18, 2024 |
|
Relapsed or Refractory CLL - With Sameer A. Parikh, MBBS, and Alessandra Ferrajoli, MD
|
Jan 17, 2024 |
|
CLL Frontline Treatment - With Sameer A. Parikh, MBBS, & Alessandra Ferrajoli, MD
|
Jan 16, 2024 |
|
Sabestomig in Non-Small Cell Lung Cancer: Bi-Specific Antibody Safe and Active
|
Nov 30, 2023 |
|
Radicals Study Finds Adjuvant Radiotherapy No Benefit After Radical Prostatectomy
|
Nov 22, 2023 |
|
Two Drug Combination Benefits Patients with nRAS-Mutated Melanoma Refractory to Checkpoint Inhibition
|
Nov 16, 2023 |
|
Collagen-Bound Interleukin 12 Converts “Cold” Tumors into “Hot” Ones
|
Nov 16, 2023 |
|
Double TKI Therapy Improves Responses in MET Amplification-Driven EGFR-Mutant Non-Small Cell Lung Cancer
|
Nov 16, 2023 |
|
CLIC Protein Inhibition Key to Metformin’s Anti-Neoplastic Properties
|
Nov 15, 2023 |
|
Adjuvant ATR Inhibition Prolonged Life in Patients with Relapsed Small Cell Lung Cancer
|
Nov 14, 2023 |
|
Mitophagy Discovered as Potential Reason for AML’s Resistance to Venetoclax
|
Nov 13, 2023 |
|
Unintentional Bias of Breast Cancer Randomized Clinical Trial Interpretations Through Discontinuation Imbalance
|
Aug 31, 2023 |
|
Trastuzumab Deruxtecan Benefits Patients with HER2-Low Metastatic Breast Cancer Irrespective of ER Expression
|
Aug 22, 2023 |
|
Artificial Intelligence Model Predicts Overall Survival in Patients with Metastatic Breast Cancer
|
Aug 18, 2023 |
|
Axillary Dissection in Older Women With Clinically Node-Negative Breast Cancer
|
Aug 11, 2023 |
|
Variability of Biological Parameters Between Tumor Biopsy & Surgical Samples in Breast Cancer Patients
|
Aug 07, 2023 |
|
Full Compliance With Adjuvant Endocrine Therapy Brings 15 Percent Superior Survival in Patients With Breast Cancer
|
Jul 25, 2023 |
|
Being Obese & Overweight Reduces Efficacy of Extended Endocrine Therapy in HR+ Breast Cancer
|
Jul 17, 2023 |
|
ASCO 2023: Neoadjuvant Pembrolizumab Brought Big Benefit in Early-Stage Non-Small Cell Lung Cancer with Heather A. Wakelee, MD, FASCO
|
Jun 30, 2023 |
|
ASCO 2023: How AI Can Help Physicians Communicate with Dying Patients Better & Also Reduce Costs
|
Jun 28, 2023 |
|
Targeted Adjuvant Therapy in Non-Small Cell Lung Cancer with Roy Herbst, MD PhD
|
Jun 27, 2023 |
|
Targeted Adjuvant Therapy in Non-Small Cell Lung Cancer with Roy Herbst, MD PhD
|
Jun 22, 2023 |
|
Emerging Cancer Treatments for Esophageal Cancer with Brian Henick, MD
|
May 12, 2023 |
|
Meet the New Oncology Times Editorial Board Chair: Stephanie L. Graff, MD, FACP
|
Apr 12, 2023 |
|
Ravi B. Parikh, MD, on How Machine Learning-Triggered Reminders Can Improve End-of-Life Care for Cancer Patients
|
Mar 15, 2023 |
|
Deanna Gerber, MD, on Navigating Cervical Cancer Screening
|
Feb 22, 2023 |
|
January Research Review: Promising Results in HemOnc Clinical Trials
|
Jan 27, 2023 |
|
Unraveling a Complex Disease: Gary K. Schwartz, MD, on Sarcoma Research Highlights, Targeted Agents & Future Directions
|
Dec 22, 2022 |
|
ASH 2022: David Sallman, MD, Discusses Positive Phase I Dose Escalation Data for PRGN-3006 UltraCAR-T in AML Patients
|
Dec 20, 2022 |
|
Anil K. Rustgi, MD, on the Current State of Colorectal Cancer Screening
|
Nov 23, 2022 |
|
Small Bytes: Phase I Study Finds Pan-AKT Inhibitor Ipatasertib Safe & Effective, Featuring Carolyn McCourt, MD
|
Nov 15, 2022 |
|
Small Bytes: How ctDNA Liquid Biopsies Can Detect Myeloid Malignancies & Occult Tumors
|
Nov 15, 2022 |
|
Dr. Lisa Newman on Eliminating Racial Disparities in Breast Cancer
|
Oct 28, 2022 |
|
HemOnc Highlights: Dr. Naveen Pemmaraju on the Benefits of Tagraxofusp for Patients with Blastic Plasmacytoid Dendritic Cell Neoplasm
|
Oct 17, 2022 |
|
5 Questions on Making Cardio-Oncology More Accessible to Diverse Patient Populations with Dr. Sandeep Mittan
|
Oct 01, 2022 |
|
ESMO 2022: For Desmoid Tumor, First Proven Therapy Shows Clear Benefit, “Should Become Standard”
|
Sep 21, 2022 |
|
ESMO 2022: PATHFINDER Presents Screening Paradigm Shift with A Blood Test to Facilitate Early Detection
|
Sep 15, 2022 |
|
OncTimes Talk Research Review August 2022: Focus on Breast Cancer
|
Aug 25, 2022 |
|
Metastatic Hormone-Sensitive Prostate Cancer: Extending Life By Adding a Third Drug to Standard Regimens with Dr. Vincent Khoo
|
Aug 09, 2022 |
|
Liquid Biopsy ctDNA Prediction of Lung Cancer Relapse “Ready for Prime Time”
|
Jul 19, 2022 |
|
ASCO 2022 Small Bytes Episode 3: Dr. Marla Lipsyc-Sharf on Personalized ctDNA Testing in Late, HR+, HER2-Negative Breast Cancer
|
Jun 21, 2022 |
|
ASCO 2022 Small Bytes Episode 2: Dr. Julia C. Tchou on Telehealth Weight Loss Program for Breast Cancer Survivors
|
Jun 10, 2022 |
|
ASCO 2022 Small Bytes: Dr. Alexander I. Spira on KRYSTAL-1 for Patients with Advanced/Metastatic NSCLC
|
Jun 06, 2022 |
|
Colleague Conversations: A Look at Germline Predisposition to Hematologic Malignancies
|
May 23, 2022 |
|
Refugees & Cancer Care: Ukraine, Lebanon & Beyond Featuring Dr. Richard Sullivan & Dr. Deborah Mukherji
|
Apr 18, 2022 |
|
Unpacking the Role of Emotions in Mastectomy Decisions with Clara N. Lee, MD
|
Apr 04, 2022 |
|
Mitigating the Effects of Climate Change on Cancer Care With Robert A. Hiatt, MD, PhD
|
Mar 21, 2022 |
|
Roswell Park’s Candace S. Johnson & Congressman Brian Higgins on the Promise of Biden’s Cancer Moonshot
|
Mar 07, 2022 |
|
ASH 2021 Revisited: Plenary Sessions, ZUMA-7 & COVID Vaccines
|
Feb 21, 2022 |
|
OncTimes Talk Research Review February 2022: Dr. Stephen Hahn, COVID, 2021 World Cancer Leaders’ Summit & Cervical Cancer News
|
Feb 07, 2022 |
|
ASH 2021 Recap: COVID-19 in Patients with Acute Leukemias & Myelodysplasia In Conversation with Dr. Pinkal Desai
|
Dec 20, 2021 |
|
ASH 2021 Recap: Multi Omics Sheds New Light on Malignant Transformation from Myeloproliferative Neoplasm to AML
|
Dec 15, 2021 |
|
Study Recap: After 6 Months, Pfizer COVID Vaccine Remains Effective Against Hospitalizations
|
Nov 10, 2021 |
|
Research Spotlight: MET Amplification as Driver for NSCLC
|
Sep 07, 2021 |
|
Colleague Conversations: Palliative Care in Oncology
|
Sep 07, 2021 |
|
OncTimes Talk Research Review May 2021
|
May 13, 2021 |
|
Straight Talk with Dr. Brian J. Bolwell: Values
|
Nov 21, 2020 |
|
Straight Talk with Dr. Brian J. Bolwell: Moments
|
Sep 24, 2020 |
|
Young Investigators: Liam Holt, PhD, Examines High Compression on Cells & Cancer
|
Sep 24, 2020 |
|
Straight Talk with Dr. Brian Bolwell: Letting it Go
|
Jul 17, 2020 |
|
Talking About Leadership With Brian J. Bolwell, MD, FACP
|
Jan 28, 2019 |
|
A Closer Look at Ultra-Rare Cancers
|
Nov 09, 2018 |
|
What I Love About Hematology/Oncology: Muzaffar H. Qazilbash, MD
|
Oct 31, 2018 |
|
What I Love About Hematology/Oncology: Pamela Crilley, DO
|
Sep 24, 2018 |
|
What I Love About Hematology/Oncology: Margaret Kasner, MD, MSCE
|
Sep 24, 2018 |
|
How Health IT is Changing Oncology
|
Apr 21, 2014 |
|
Are You Providing Adequate Palliative Care?
|
Apr 21, 2014 |
|
CMS Innovation
|
Apr 21, 2014 |
|
Are You Giving Patients What They Want?
|
Oct 26, 2013 |
|
Chemotherapy Order Sets—Lessons Learned
|
Oct 26, 2013 |
|
A Clinical Research Consortium for MDS
|
Aug 07, 2013 |
|
The Role of Patient Education in Survivorship Care
|
Aug 07, 2013 |
|
How CancerLinQ Will Change Patient Care
|
Aug 07, 2013 |
|
The Thinking Behind ASCO’s Top Five List
|
Jul 03, 2013 |
|
How Drug Shortages Affect Oncology
|
Jul 01, 2013 |
|
Oncology Practices Expect Big Change
|
Mar 01, 2013 |
|
The Value of In-Person Meetings
|
Mar 01, 2013 |
|
Cancer’s Existential Impact on Survivors
|
Jan 23, 2013 |
|
How Should Physicians Be Paid?
|
Jan 21, 2013 |
|
Integrating Palliative & Standard Care
|
Nov 16, 2012 |
|
The Importance of “Competitive Mortality” in Oncology Care
|
Nov 16, 2012 |
|
Will CMS Cast Its Eye Toward Oncology?
|
Sep 12, 2012 |
|
Final Rule for Medicare ACOs
|
Sep 12, 2012 |
|
Multiple Myeloma: Big Survival Gains from Novel Agents 'in the Real World'
|
Aug 05, 2010 |
|
From the European Hematology Association 2010 Congress: For Patients with Follicular Lymphoma, Rituximab Maintenance Therapy Cuts Risk of Recurrence in Half (Phase III PRIMA Study)
|
Jun 17, 2010 |
|
OT Clinical Advisory Editor for Hematology/Oncology Mikkael Sekeres, MD, MS
|
Apr 09, 2010 |
|
OT Clinical Advisory Editor for Oncology Ramaswamy Govindan, MD
|
Apr 09, 2010 |
|
Treatment Recommendations for High- & Low-Risk Early Breast Cancer: New Data from EBCC 7, the European Breast Cancer Conference
|
Apr 09, 2010 |
|
Pregnancy & Breast Cancer: New Updates from EBCC 7, the European Breast Cancer Conference
|
Apr 01, 2010 |
|
Program 4, Day 4, Monday Dec 8
|
Dec 09, 2009 |
|
Program 3, Monday Dec 7
|
Dec 08, 2009 |
|
Program 1, First Day, Dec. 5
|
Dec 07, 2009 |
|
Program 2, Sunday Dec. 6
|
Dec 07, 2009 |
|
Aromatase Inhibitor Better than Tamoxifen for Initial Adjuvant Therapy for HR- Positive Breast Cancer, But Compliance an Issue!
|
Oct 13, 2009 |
|
Longer Follow-up Reveals: Aspirin Prevents Cancer in Lynch Syndrome
|
Oct 13, 2009 |
|
Swedish Registry Study Shows Hormone Therapy for Prostate Cancer Increased All Cardiovascular Mortality
|
Oct 13, 2009 |
|
The Disappointment of the NSABP C-08 Trial
|
Oct 13, 2009 |
|
Research Policy Expert: Overhaul Cancer Research Priorities Globally Now!
|
Oct 13, 2009 |
|
Advanced Biliary Cancer Controlled with Cetuximab Added to GEMOX
|
Sep 02, 2009 |
|
Metastatic Colorectal Cancer: Capecitabine Equivalent to 5-FU in Irinotecan/Bevacizumab Combos
|
Sep 02, 2009 |
|
Stage IV Pancreatic Islet Cell Tumors: Sunitinib Doubles Progression-Free Survival in Phase III Study
|
Sep 02, 2009 |
|
NCRI Conference, ASCO Annual Meeting, and Perspectives in Lung Cancer European Congress
|
Jul 21, 2009 |
|
ASH Annual Meeting
|
Jul 21, 2009 |
|
More from the ASH Annual Meeting!
|
Jul 21, 2009 |
|
10th European Congress on Perspectives in Lung Cancer, Brussels
|
Jul 21, 2009 |
|
Bilateral Prophylactic Mastectomy for DCIS
|
Jul 21, 2009 |
|
Cancer-Related Fatigue
|
Jul 21, 2009 |
|
The Smartest Oncologist in the World? – Well, at least in the US!
|
Jul 21, 2009 |
|
Breast Cancer: St. Gallen Meeting Endorses Multi-Gene Assays for Refining Chemo Decision
|
Jul 21, 2009 |
|
Oropharyngeal Cancer: Better Outlook with HPV-Directed Therapies
|
Jul 21, 2009 |
|
CML: Hagop Kantarjian on Treating Patients with the T315I Mutation
|
Jul 21, 2009 |
|
KRAS-Driven Selection of Molecular Therapy for Metastatic Colorectal Cancer: Choosing Between Bevacizumab, Cetuximab, Panitumomab, or a Combination
|
Jul 21, 2009 |